A special section on Non-Coding RNAs is being planned for publication in the August 2022 issue of Journal of Pharmacology and Experimental Therapeutics.
The submission deadline is April 2, 2022.
Original research pertaining to innovative systems based on non-coding RNAs and their emerging clinical applications will be considered for this special section. Manuscripts describing efforts in demonstrating the role of non-coding RNAs as a biomarker of disease as well as their emerging functional role as targets to treat human disease are especially welcome. Research papers describing innovative in vitro/ex vivo/in vivo, bioanalytical, -omics, modeling, and/or clinical research approaches to advance the understanding of the biological properties of non-coding RNAs, are highly encouraged. Reports on animal models addressing any of these topics will be considered if a clear translation to humans is shown.
Review articles addressing any aspects of the aforementioned topics will be considered as well; proposals for such articles should be sent to the guest editors, Dr. Roberto Levi (email@example.com) and/or Dr. Gaetano Santulli (firstname.lastname@example.org), for approval prior to submission.